Novanta INC 10-Q quarterly reports

Novanta Inc. announced a 10.3% increase in total revenue for the six months ended July 3, 2026, driven by robust performance in both its Automation Enabling Technologies and Medical Solutions segments.

Novanta Inc. reported a 10.4% increase in revenue for the first quarter of 2026, reaching $257.7 million, driven by growth in both its segments, though earnings per share saw a decline.

Novanta Inc. reported a significant decline in net income and earnings per share for the third quarter and first nine months of 2025, despite modest revenue growth, driven by increased operating expenses and restructuring costs.

Novanta Inc. reports a 2.2% revenue increase for Q2 2025, driven by acquisitions and Automation Enabling Technologies, but operating income and EPS declined due to higher restructuring and acquisition costs.

Novanta Inc. saw a slight increase in revenue and a significant jump in operating income for the first quarter of 2025, driven by growth in the Automation Enabling Technologies segment and a gain on the sale of a facility.

Novanta Inc.'s Q3 2024 results show revenue growth driven by acquisition, but profitability is impacted by integration costs and market softness.

Novanta Inc.'s Q2 2024 results show revenue growth driven by acquisition, but operating income declined due to increased expenses and weaker industrial demand.

Novanta Inc.'s first quarter 2024 results show a revenue increase driven by acquisition, but a slight decrease in operating income due to higher expenses.